[{"data":1,"prerenderedAt":148},["ShallowReactive",2],{"drug-cyclopentolate":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":34,"contraindications":48,"warnings":58,"renal":59,"monitoring":60,"interactions":61,"review":62,"examples":65,"atc":71,"iran":73,"links":93,"populations":108,"usApproval":143},"cyclopentolate",1,{"fa":7,"en":8},"قطره سیکلوپنتولات","Cyclopentolate eye drops","sensory-organs",{"fa":11,"en":12},"سیکلوپلژیک","Cycloplegic",[14],{"name":15,"market":16},"Cyclogyl","US",[18,19,20],"cyclogyl","سیکلوژیل","سیکلوپنتولات",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":29,"refs":30},"drops-1","eye-drops","ophthalmic","1% ophthalmic solution",{"amount":5,"unit":28,"perUnit":28},"drop",[16],[31],{"source":32,"section":33},"fda-cyclopentolate","How Supplied",[35],{"id":36,"disease":37,"label":38,"population":41,"type":42,"unit":28,"dose":43,"refs":45},"refraction","eye-examination",{"fa":39,"en":40},"رفرکشن سیکلوپلژیک — ۱ تا ۲ قطره، تکرار پس از ۵ تا ۱۰ دقیقه در صورت نیاز","Cycloplegic refraction — 1–2 drops, repeat after 5–10 min if needed",{},"fixed",{"perDose":5,"dosesPerDay":44},2,[46],{"source":32,"section":47},"Dosage and Administration",[49],{"id":50,"severity":51,"text":52,"refs":55},"hyper","block",{"fa":53,"en":54},"حساسیت به اجزای فرآورده.","Hypersensitivity to any component.",[56],{"source":32,"section":57},"Contraindications",[],[],[],[],{"status":63,"reviewer":64,"date":64},"unverified",null,[66],{"regimen":36,"formulation":23,"input":67,"expect":70},{"ageYears":68,"weightKg":69},8,25,{"perDose":5},[72],"S01FA04",{"status":74,"forms":75,"refs":88},"registered",[76,80,84],{"code":77,"en":78,"fa":79},"06747","CYCLOPENTOLATE HCL 0.5% 5ML OPH DROP","قطره چشمی سیکلوپنتولات هیدروکلراید ۰٫۵ درصد ۵ میلی‌لیتر",{"code":81,"en":82,"fa":83},"00367","CYCLOPENTOLATE HCL 1% 10ML OPH DROP","قطره چشمی سیکلوپنتولات هیدروکلراید ۱ درصد ۱۰ میلی‌لیتر",{"code":85,"en":86,"fa":87},"50838","CYCLOPENTOLATE HYDROCHLORIDE SOLUTION OPHTHALMIC 1 % 5 mL","محلول سیکلوپنتولات هیدروکلراید ۱ درصد ۵ میلی‌لیتر",[89],{"source":90,"section":91,"url":92},"darooyab-generic","G-877\u002FCyclopentolate","https:\u002F\u002Fwww.darooyab.ir\u002FG-877\u002FCyclopentolate",[94,98,102,105],{"kind":95,"url":96,"label":97},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=084109","ANDA084109",{"kind":99,"url":100,"label":101},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=1d008c76-7210-4ace-90fa-7cd22762e12e","FDA Cyclogyl",{"kind":103,"url":104,"label":72},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01FA04",{"kind":106,"url":92,"label":107},"darooyab","Cyclopentolate",{"pregnancy":109,"lactation":118,"pediatric":126,"geriatric":134},{"level":110,"text":111,"quote":114,"refs":115},"caution",{"fa":112,"en":113},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Animal reproduction studies have not been conducted with cyclopentolate.",[116],{"source":32,"section":117},"Precautions\u002FWarnings – Pregnancy",{"level":110,"text":119,"quote":122,"refs":123},{"fa":120,"en":121},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when cyclopentolate hydrochloride is administered to a nursing woman.",[124],{"source":32,"section":125},"Precautions\u002FWarnings – Nursing Mothers",{"level":110,"text":127,"quote":130,"refs":131},{"fa":128,"en":129},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances in pediatric patients.",[132],{"source":32,"section":133},"Precautions\u002FWarnings – Pediatric Use",{"level":135,"text":136,"quote":139,"refs":140},"ok",{"fa":137,"en":138},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness have been observed between elderly and younger patients.",[141],{"source":32,"section":142},"Precautions\u002FWarnings – Geriatric Use",{"kind":144,"refs":145,"id":97},"ANDA",[146],{"source":32,"section":147},"SPL approval \u002F marketing category",1792092029629]